Weight Loss News
-
Tirzepatide and Eloralintide: Exciting new weight loss results
In the latest trial results Eloralintide and Tirzepatide produced greater weightloss vs either product by themselves but a considerable amount – up to 23.3% body weight. Weight Loss akin to Metabolic Surgery Results Eloralintide is a once-weekly selective amylin receptor agonist, while tirzepatide is a dual GIP/GLP-1 receptor agonist. Their combination therefore targets three nutrient-stimulated…


